RAPT RAPT Therapeutics, Inc.
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.
$16.91 +0.91 (5.69%)
As of 03/05/2021 15:59:58 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
06/28/2019
24,555,259
119,395
$415,229,430
0.00%
SEC Edgar Online
10-Q
10-K
75382E109
US75382E1091
BK5T6R0
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
06/28/2019
24,555,259
119,395
$415,229,430
0.00%
SEC Edgar Online
10-Q
10-K
75382E109
US75382E1091
BK5T6R0
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-10.34
3.76
111.02
-48.50%
-1,427.09%
3.76
111.02
-48.50%
-1,427.09%